awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36012867-EEEF51F4-A439-4CF9-8A5C-C37D311DC597
Q36012867-EEEF51F4-A439-4CF9-8A5C-C37D311DC597
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36012867-EEEF51F4-A439-4CF9-8A5C-C37D311DC597
Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome
P2860
Q36012867-EEEF51F4-A439-4CF9-8A5C-C37D311DC597
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36012867-EEEF51F4-A439-4CF9-8A5C-C37D311DC597
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
904a720ce69341a749eb784b88ef5008fdc45911
P2860
In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control.